APOBEC3B predicts good prognosis with gemcitabine plus platinum therapy in patients with mUC Feb. 20, 2020
resTORbio presents interim phase Ib/IIa data for RTB-101 in PD along with corporate update Feb. 20, 2020
Dose-escalation data presented from phase Ib/II study of cetrelimab plus erdafitinib in mUC Feb. 20, 2020
GLP1R agonist-DYRK1A inhibitor combination enhances beta cell proliferation with better specificity Feb. 20, 2020
RSS